SGP (SpyGlass Pharma, Inc. Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by SGP officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-11 | Bilal Arshad Khan | Director | Buy | — | — |
| 2026-02-11 | Ali Behbahani | Director | MIXED | — | — |
| 2026-02-11 | Mohamad Makhzoumi | 10%+ Owner | MIXED | — | — |
| 2026-02-11 | FOREST BASKETT | 10%+ Owner | MIXED | — | — |
| 2026-02-11 | Paul Edward Walker | 10%+ Owner | MIXED | — | — |
| 2026-02-11 | Rajeev M. Shah | Director | MIXED | — | — |
| 2026-02-11 | Carmen Chang | 10%+ Owner | MIXED | — | — |
| 2026-02-11 | Rick Yang | 10%+ Owner | MIXED | — | — |
| 2026-02-11 | Anthony A. Florence Jr. | 10%+ Owner | MIXED | — | — |
| 2026-02-11 | Geoffrey B Pardo | Director | MIXED | — | — |
| 2026-02-11 | Edward T Mathers | 10%+ Owner | MIXED | — | — |
| 2026-02-11 | Kirk G. Nielsen | Director | C | — | — |
| 2026-02-11 | NEA 17 GP, LLC | 10%+ Owner | MIXED | — | — |
| 2026-02-11 | SCOTT D SANDELL | 10%+ Owner | MIXED | — | — |
| 2026-02-10 | Kirk G. Nielsen | Director | MIXED | — | — |
| 2026-02-10 | Vensana Capital I, L.P. | 10%+ Owner | MIXED | — | — |
| 2026-02-09 | Geoffrey B Pardo | Director | A | — | — |
| 2026-02-09 | Michael Dybbs | Director | A | — | — |
| 2026-02-09 | Chetan Pratap Pujara | Chief R&D Officer | A | — | — |
| 2026-02-09 | Kirk G. Nielsen | Director | A | — | — |
| 2026-02-09 | Patrick H. Mooney | Chief Executive Officer | A | — | — |
| 2026-02-09 | Malik Y. Kahook | See remarks | A | — | — |
| 2026-02-09 | James Robert Dennewill Jr. | Chief Operating Officer | A | — | — |
| 2026-02-09 | Jean-Frederic Viret | Chief Financial Officer | A | — | — |
| 2026-02-09 | Habib J Dable | Director | A | — | — |
| 2026-02-09 | Elizabeth G. O'Farrell | Director | A | — | — |
| 2026-02-09 | Bilal Arshad Khan | Director | A | — | — |
| 2026-02-09 | Ali Behbahani | Director | A | — | — |
| 2026-02-09 | Zachary Scheiner | Director | A | — | — |
| 2026-02-09 | Peter Kolchinsky | Director | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | 10%+ Owner | 6,035,038 | — |
| — | 10%+ Owner | 6,035,038 | — |
| — | 10%+ Owner | 5,097,538 | — |
| — | 10%+ Owner | 5,097,538 | — |
| — | Director | 3,310,619 | — |
| — | 10%+ Owner | 3,310,619 | — |
| — | 10%+ Owner | 2,989,408 | — |
| — | 10%+ Owner | 2,989,408 | — |
| — | Director | 2,989,408 | — |
| — | 10%+ Owner | 2,989,408 | — |
| — | Director | 2,054,678 | — |
| — | Director | 1,875,013 | — |
| — | 10%+ Owner | 1,619,240 | — |
| — | 10%+ Owner | 954,990 | — |
| — | Director | 276,877 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the SGP quote page; the site-wide leaderboard is on the insider transactions hub.